Emerging functions of mammalian mitochondrial fusion and fission by Chen, Hsiuchen & Chan, David C.
Emerging functions of mammalian mitochondrial
fusion and fission
Hsiuchen Chen and David C. Chan*
Division of Biology, California Institute of Technology, 1200 E. California Boulevard, MC114-96, Pasadena,
CA 91125, USA
Received June 8, 2005; Revised and Accepted July 14, 2005
Mitochondria provide a myriad of services to the cell, including energy production, calcium buffering and
regulation of apoptosis. How these diverse functions are coordinated among the hundreds of mitochondria
in a given cell is largely unknown, but is probably dependent on the dynamic nature of mitochondria. In this
review, we explore the latest developments in mitochondrial dynamics in mammals. These studies indicate
that mitofusins and OPA1 are essential for mitochondrial fusion, whereas Fis1 and Drp1 are essential for
mitochondrial fission. The overall morphology of the mitochondrial population depends on the relative activi-
ties of these two sets of proteins. In addition to the regulation of mitochondrial shape, these molecules also
play important roles in cell and tissue physiology. Perturbation of mitochondrial fusion results in defects in
mitochondrial membrane potential and respiration, poor cell growth and increased susceptibility to cell
death. These cellular observations may explain why mitochondrial fusion is essential for embryonic develop-
ment. Two inherited neuropathies, Charcot–Marie–Tooth type 2A and autosomal dominant optic atrophy, are
caused by mutations in mitofusin 2 and OPA1, suggesting that proper regulation of mitochondrial dynamics
is particularly vital to neurons. Mitochondrial fission accompanies several types of apoptotic cell death and
appears important for progression of the apoptotic pathway. These studies provide insight into how mito-
chondria communicate with one another to coordinate mitochondrial function and morphology.
Recent work has highlighted the importance of mitochondrial
dynamics in cell and animal physiology. Because mitochon-
dria constantly fuse and divide, an imbalance of these two pro-
cesses dramatically alters overall mitochondrial morphology
(Fig. 1). Disruption of fusion causes the normal, tubular
network of mitochondria to fragment into short rods or
spheres (1–4). Conversely, disruption of fission generates
elongated, interconnected tubules that often cluster peri-
nuclearly (5–7). In addition to the regulation of mitochondrial
morphology, it is now clear that mitochondrial dynamics plays
additional roles in mitochondrial function.
FUSION AND FISSION PROTEINS
Mitofusins 1 and 2 (Mfn1, Mfn2) and OPA1 are essential for
mitochondrial fusion (1,2,8–10) (Fig. 2A). These proteins are
large GTPases localized to mitochondria. Mfn1 and Mfn2
show 81% homology and similar topologies (2,11–14). Both
reside on the outer membrane with the N-terminal GTPase
and a predicted coiled coil protruding into the cytosol (12).
A transmembrane region then forms a U-shaped membrane
anchor, ending in a cytosolic, C-terminal coiled coil.
OPA1 also possesses two predicted coiled coils, one
just N-terminal to the GTPase and the other at the extreme
C-terminal. OPA1 is an intermembrane space protein,
closely associated with the inner membrane (15). However,
there are at least eight splicing isoforms (16), some of which
demonstrate different localizations (17). The yeast orthologue,
Mgm1p, is produced as an integral inner membrane protein
that is cleaved into a soluble intermembrane space protein
(18–20). Both forms are required for Mgm1p function
(18,21). Such post-translational modification has yet to be
demonstrated in mammalian cells, but the mammalian
PARL protease can substitute in Mgm1p cleavage (19).
Presumably, the Mfns and OPA1 work together to promote
mitochondrial fusion. Consistent with this idea, OPA1 has
been shown to tubulate mitochondria in an Mfn1-dependent
manner (8). Mfn1 and Mfn2 can homodimerize or heterodi-
merize (2). However, no biochemical interactions have been
shown between the Mfns and OPA1 in mammalian cells. In
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yeast, immunoprecipitation studies have demonstrated weak
but reproducible associations between Fzo1p (Mfn ortho-
logue) and Mgm1p (20,22). In addition, another protein
required for fusion, Ugo1p, interacts with this complex, but
no mammalian homologue has been found.
On the fission side, at least two proteins, Fis1 and dynamin-
related protein 1 (Drp1), are required in mammals (Fig. 2B).
Drp1 exists largely in a cytosolic pool, but a fraction localizes
to puncta on mitochondria (5). Drp1 contains a dynamin-like
central domain and C-terminal GTPase effector domain
(GED) in addition to its N-terminal GTPase. Intramolecular
interactions between the GTPase and GED regions appear to
be required for full GTPase and fission activities (23). Inter-
molecular oligomerization may also be necessary, as it is
thought to be the case for dynamin. Given these similarities
with dynamin, Drp1 has been proposed to couple GTP
hydrolysis with mitochondrial membrane constriction and
fission (5).
How is Drp1 recruited to mitochondria to mediate fission?
One likely possibility is Fis1, a single-pass transmembrane
protein that is anchored to the mitochondrial outer membrane
by its C-terminal region (6). However, reduction of Fis1 levels
by RNA interference (RNAi) does not disrupt Drp1 locali-
zation to mitochondria (24). A weak, direct interaction
between Fis1 and Drp1 has been observed with recombinant
proteins, but this association remains to be demonstrated in
vivo (6). In contrast, yeast fis1 mutants lose most Dnm1p
(Drp1 orthologue) from mitochondria (25–27). Fis1p recruits
Dnm1p to mitochondria through one of the two molecular
adaptors, Mdv1p or Caf4p (28). Mdv1p, in addition, plays a
post-recruitment function in the activation of Dnm1p (28–30).
STRUCTURAL DATA
Structural studies have given insight into how these proteins
function at the molecular level. NMR (31) and crystallo-
graphic (32) studies have identified a tetratrico peptide
repeat (TPR) domain in the cytosolic portion of Fis1. TPR
motifs are packed spirals of anti-parallel a-helices. They are
involved in protein–protein interactions and seem to be
found most often in multi-protein complexes (33). In Fis1,
the cytosolic domain folds into a helical bundle with a
concave, hydrophobic surface that probably forms the
binding site for a short peptide. Given the role of yeast
Fis1p as the mitochondrial anchor for the fission machinery,
it is quite plausible that the TPR domain of Fis1 serves as a
scaffold for the assembly of a mammalian fission complex.
A crystallographic study of Mfn1 has likewise clarified the
role of Mfn1 complexes in fusion (34). Cell hybrid studies on
wild-type and Mfn-null cells indicate that Mfns are required
for apposing mitochondria during fusion. A crystal structure
of the C-terminal coiled coil (HR2) reveals that this interaction
occurs via a dimeric, anti-parallel association of the HR2
regions (Fig. 2A). Because the transmembrane anchors of
each Mfn1 molecule are on opposite sides of the coiled coil,
this HR2 interaction provides a mechanism for tethering
mitochondria. Tethered intermediates are found in other
membrane trafficking systems prior to docking and membrane
fusion. Indeed, mitochondria with Mfn1 lacking the GTPase
domain cannot complete fusion, but aggregate with a
uniform gap between them, as if trapped in a tethered
intermediate.
CELLULAR FUNCTION
The central question of mitochondrial dynamics is what role it
plays in mitochondrial and cellular functions. Clearly, fusion
and fission control mitochondrial morphology. How different
morphologies affect mitochondrial function is not clear yet,
but specific changes in mitochondrial shape during animal
development suggest that morphology and function are
indeed closely linked. In addition, mounting evidence indi-
cates that mitochondrial dynamics has roles beyond mainten-
ance of morphology. Indeed, two key functions of
mitochondria, electron transport and regulation of apoptosis,
are affected by disruption of molecules involved in mitochon-
drial fusion and fission.
Oxygen electrode studies demonstrate that both endogenous
and uncoupled respiration rates are reduced in Mfn-null cells
and even more so in cells depleted of OPA1 by RNAi
(OPA1–RNAi) (1). Attenuation of electron transport rates in
Figure 1. Relative rates of fusion and fission control mitochondrial mor-
phology. Wild-type (Wt) mouse fibroblasts have tubular mitochondria.
Inhibition of fusion (left panels) by deletion of both Mfn1 and Mfn2 (Mfn-
null) or knock-down of OPA1 (OPA1–RNAi) causes mitochondrial fragmen-
tation because of unopposed fission. Conversely, inhibition of fission (right
panels) by knock-down of Drp1 (Drp–RNAi) causes excessively elongated
and interconnected mitochondria that often collapse into perinuclear aggre-
gates (bottom right).
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respiration complexes I, III and IV contribute to this decrease.
Normal respiration profiles are restored upon re-introduction
of the fusion proteins, demonstrating reversibility of the
defect. Both Mfn-null and OPA1–RNAi cells also exhibit
reversible inhibition of cell growth and loss of mitochondrial
membrane potential. How loss of fusion causes these func-
tional defects remains to be resolved. One hypothesis is that
mitochondrial fusion protects function by allowing rapid
mixing of membrane and soluble contents, thereby ensuring
that stochastic loss of materials is only transient. Without
fusion, these losses become permanent and thus debilitating,
resulting in cellular dysfunction (2).
In mammals, mitochondria play an important role in apop-
totic cell death. Upon apoptosis induction, mitochondria often
fragment (35). In one apoptotic pathway, Bax translocates
from the cytosol to mitochondria and opens a pore in the
outer membrane (36,37). Subsequent release of intermem-
brane space factors, including cytochrome c, results in
caspase activation and ultimately, cell death (38). Both mito-
chondrial fission factors, Fis1 and Drp1, have now been impli-
cated in this pathway (39).
Upon exposure to certain apoptotic stimuli, mitochondria
accumulate more Drp1 puncta (35), which also co-localize
with Bax (40). Drp1 co-localizes with Bax in punctate struc-
tures (40). Dominant-negative Drp1 and Drp1–RNAi
prevent mitochondrial fragmentation during apoptosis, and
interestingly, also reduce cell death, suggesting that Drp1
plays a role in apoptosis (35). However, Bax translocation
still occurs, implying that Drp1 operates downstream of Bax
mitochondrial localization (24). Fis1–RNAi also inhibits
caspase-dependent cell death by several stimuli. This
anti-apoptotic effect is greater than that of Drp1-RNAi and
is accompanied by blockage of Bax translocation and
cytochrome c release (24). This finding places Fis1 upstream
of Bax mitochondrial localization and therefore suggests dis-
tinct functions for Fis1 and Drp1 during apoptosis.
It should be noted that absolute requirements for Fis1 and
Drp1 in apoptosis cannot be determined without true null
alleles. Also, evidence clearly indicates that alternative cell
death pathways exist. In fact, fission may have protective
effects in Caþþ-dependent apoptosis (41). Finally, it must
be emphasized that mitochondrial fission occurs normally in
healthy cells without leading to apoptosis.
As opposed to the fission molecules, mitochondrial fusion
molecules seem to protect cells from apoptosis. Some apopto-
tic stimuli reduce mitochondrial fusion (42). Although
co-overexpression of Mfn1 and Mfn2 can reduce cell death
in the presence of apoptotic stimuli (43), OPA1-RNAi (24)
and rat Mfn-RNAi (43) increase sensitivity to apoptotic
stimuli. In fact, OPA1-RNAi even causes some spontaneous
apoptosis (4).
Taken together, these studies suggest a model in which
mitochondrial fission facilitates mammalian apoptosis,
whereas mitochondrial fusion plays a protective role. The
mechanisms involved are open to speculation. Mitochondrial
fission may enhance apoptosis by increasing the availability
of outer membrane surface area for pore formation. Because
disruption of membrane continuity is inherent to the fission
process, it is also possible that the fission machinery itself par-
ticipates in outer membrane permeabilization. Mitochondrial
fusion could protect from apoptosis by acting as a repair
mechanism for outer membrane damage.
Figure 2. Mitochondrial fusion and fission molecules. (A) Fusion molecules. Mfn is a mitochondrial outer membrane protein with a cytosolic GTPase domain
(orange oval) and two coiled coil regions (coils). The C-terminal coiled coil mediates oligomerization between Mfn molecules on adjacent mitochondria. OPA1
(white oval) is a GTPase in the intermembrane space. Mfns and OPA1 coordinate mitochondrial fusion, as shown by mixing of green and red matrix markers to
produce yellow. (B) Fission molecules. Fis1 is localized uniformly to the mitochondrial outer membrane, whereas Drp1 is localized to the cytosol and punctate
spots on mitochondria. Some of these spots are constriction sites that lead to mitochondrial fission. The mechanism of Drp1 recruitment to mitochondria is
unclear.
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PHYSIOLOGICAL IMPACT
How do the cellular functions of mitochondrial dynamics dis-
cussed previously influence the organism as a whole? Some
insights have been gained from engineered and naturally
occurring mutations in the Mfns and OPA1. These mutations
have been implicated in developmental problems, neuropa-
thies, obesity and vascular diseases (Fig. 3).
A targeted null mutation of either Mfn1 or Mfn2 results in
mid-gestational lethality (2). Mfn1-null mice are easily distin-
guished by their severe developmental delay and distorted
features. Mfn2-null embryos, however, are relatively normal
until they die from defects of the placenta. These pheno-
types indicate that mitochondrial fusion is required during
development and that Mfn1 and Mfn2 are not completely
redundant. Because the lethal nature of the null alleles pre-
clude studying mitochondrial fusion in adult tissues, we
have also engineered conditional alleles. Preliminary studies
indicate that the nervous system is severely affected by the
loss of Mfn2. Interestingly, a naturally occurring neuropathy
is also associated with Mfn2 mutations.
Charcot–Marie–Tooth syndrome (CMT) is a cluster of her-
editary peripheral motor neuropathies, some of which have
concomitant sensory loss (44,45). CMT presents with pro-
gressive distal muscle weakness followed by muscular
atrophy. Traditionally, clinical criteria have divided CMT
into different subgroups. The two largest subgroups, CMT1
and CMT2, were thought to represent primary disorders in
Figure 3. Mammalian tissues affected by defects in fusion molecules. OPA1 mutations cause defects in the retina and optic nerve. Mfn2 mutations affect the
placenta, skeletal muscle, vascular smooth muscle cells and peripheral motor neurons.
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Schwann cells and motor neurons, respectively. However, it is
now clear that defects in one cell type can affect the other cell
type and that different mutations in the same gene can cause
both CMT1 and CMT2.
Mfn2 has been identified as the gene mutated in CMT2A, a
dominantly inherited form of CMT (46). Thus far, 15 different
mutations have been found in 21 families (46,47). Most
mutations cluster in the GTPase domain or just upstream of
it. The pathogenesis of CMT2A is unclear. Haploinsufficiency
has been suggested, but Mfn2 þ/2mice exhibit no motor
defects (2). Whether this is a true difference between mice
and humans, possibly because of the vastly different axonal
lengths of peripheral nerves, is yet to be determined. Alterna-
tively, the mutant Mfn2 alleles may have dominant-negative
or gain of function activity.
Another neuropathy linked to mitochondrial fusion is auto-
somal-dominant optic atrophy (ADOA) (48). This most fre-
quent form of hereditary optic neuropathy is characterized
by progressive loss of visual acuity, with wide ranges in
both expressivity and penetrance. Histopathology indicates
that primary degeneration of the retinal ganglia proceeds to
atrophy of the optic nerve. The predominant gene responsible
for ADOA has been identified as OPA1 (49,50). At least
83 different OPA1 mutations have been reported (51). Most
represent gene truncations, with more than 50% found in the
GTPase domain and the 30 coiled coil region. Missense
mutations are almost exclusively found in the GTPase
domain. Some mutations may be semi-dominant, because
one compound heterozygote patient has been reported to
have more severe symptoms than the patient’s simple-hetero-
zygote parents and siblings (52). A family with a deleted
OPA1 gene (53) and others with an exon 1 null mutation
(52) indicate that haploinsufficiency may also be a cause.
How OPA1 mutations affect mitochondrial function in
retinal ganglion cells is not clear yet, but recent studies
provide tantalizing hints at mitochondria dysfunction.
Clumped mitochondria in monocytes of affected patients indi-
cate that mitochondrial morphology and/or localization is
altered (50). Copy number of mitochondrial DNA (mtDNA)
molecules was found to be lower in OPA1 patients (54).
Finally, oxidative phosphorylation was shown to be deficient
in calf muscle of patients (55).
It may not be a coincidence that two human diseases caused
by defects in mitochondrial fusion genes are neurodegenera-
tive disorders. Many mtDNA mutations also cause neurologi-
cal problems. One common hypothesis for why neurons are so
sensitive to changes in mitochondrial function is that neurons
have high energy demands and/or require calcium regulation
at distinct areas which may be quite distant from the cell
body, namely axons or dendrites. Therefore, mitochondrial
deficiencies may result in non-functional synapses, axonal
degeneration and perhaps ultimately, cell death. This hypoth-
esis has supporting evidence. Nerve growth factor (NGF) is a
neurotrophin essential for the development and survival of
sensory neurons. Interestingly, NGF induces mitochondrial
migration down axons and accumulation at the NGF source
(56). Similarly, time lapse microscopy demonstrates that a
critical mitochondrial mass is required for dendritic spine
development and maintenance (57). A mutation in the
Drosophila milton gene prevents mitochondrial transport to
synaptic terminals of photoreceptor cells, resulting in blind
flies (58). Finally, Drosophila with mutations in Drp1 show
reduced numbers of mitochondria at synapses and are unable
to sustain neurotransmission under prolonged stimulation,
probably due to improper mobilization of reserve pool vesicles
(59). These findings strongly underscore the neuronal require-
ment for mitochondria in dendrites and axons. As discussed
earlier, mitochondrial dynamics affects both mitochondrial
localization and function and therefore would be expected to
influence neuronal function.
Mfn2 may also play a role in two other disorders. Mfn2 was
identified as a hypertension-suppressor gene by differential
display (60). Rat cell culture studies and in vivo work show
that overexpression of Mfn2 can inhibit vascular smooth
muscle cell proliferation, although this effect appears indepen-
dent of its mitochondrial function. A screen of differentially
expressed genes from skeletal muscle of obese rats identified
Mfn2 as a suppressor of obesity (61). Obese human subjects
also expressed less Mfn2 than lean ones. Repression of
Mfn2 expression in myotubes is associated with fragmentation
of the mitochondrial network, reduction in glucose oxidation
and diminished mitochondrial membrane potential (62).
CONCLUSION
Mitochondrial dynamics has been shown to play a critical role
in determining mitochondrial morphology and function. In
turn, developmental and physiological processes depend on
these cellular functions. The best proof of this principle is
the existence of human diseases caused by mutations in mito-
chondrial fusion genes.
Future directions in mammalian mitochondrial dynamics
include identifying all molecular constituents of the fusion
and fission machineries. This may require an in vitro assay
for these activities, much like that already developed in
yeast (63). Structural studies like those done for Mfn1 and
Fis1 will be invaluable for elucidating the mechanism of
these membrane remodelling events. Cell biological work is
needed to reveal additional consequences of fusion and
fission on mitochondrial and cellular functions. Two critical
questions are how morphology affects function and how mito-
chondrial dynamics affects function independently of
morphology. Finally, human and mouse genetic studies will
be essential in uncovering the physiological functions of mito-
chondrial dynamics. Such genetic studies will in turn provide
tools to clarify the biochemical interactions of these fusion and
fission proteins and the basic cellular biology of mitochondrial
dynamics.
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